Functional genomics identifies novel genes essential for clear cell renal cell carcinoma tumor cell proliferation and

Christina A Von Roemeling1, Laura A Marlow1, Derek C Radisky1

  • 1Department of Cancer Biology, Mayo Clinic Comprehensive Cancer Center, Jacksonville, Florida.

Oncotarget
|July 1, 2014
PubMed

Insights

Researchers identified new genes driving clear cell renal cell carcinoma (ccRCC) progression. This study reveals novel therapeutic targets and biomarkers for advanced ccRCC, offering hope for improved patient outcomes.

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • Advanced clear cell renal cell carcinoma (ccRCC) lacks effective targeted therapies for long-term disease management.
  • Understanding the genetic factors driving tumor initiation and progression is crucial for developing new treatments.

Purpose of the Study:

  • To identify novel genes and pathways involved in clear cell renal cell carcinoma (ccRCC) tumorigenesis.
  • To discover potential therapeutic targets and biomarkers for advanced ccRCC.

Main Methods:

  • High-throughput genetic analysis of patient ccRCC tissues to identify overexpressed transcripts.
  • High-throughput lentivirus screening of 195 overexpressed genes in ccRCC cell lines to assess proliferative impact.
  • Functional characterization of identified genes in tumor cell invasion.

Main Results:

  • Gene array analysis revealed transcripts consistently elevated in ccRCC compared to normal renal tissues.
  • A lentivirus screen identified 31 "hits" (genes) that significantly contribute to ccRCC cell proliferation.
  • Several identified genes are novel to ccRCC and cancer biology, with some implicated in tumor invasion.

Conclusions:

  • The study uncovers critical pathways involved in ccRCC tumorigenicity.
  • Novel candidate factors have been identified for potential therapeutic intervention in ccRCC.
  • These findings suggest new diagnostic or prognostic biomarkers for advanced ccRCC patients.

Related Concept Videos

Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.9K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

5.8K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.9K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

2.6K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
3.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K